MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202541132882 A) filed by Jss College Of Pharmacy - Jss Academy Of Higher Education & Research, Ooty, Tamil Nadu, on Dec. 29, 2025, for 'a receptor-targeted nanoparticulate drug delivery composition for treating colon carcinoma.'
Inventor(s) include Dr. Jawahar Natarajan; Mr. Syed Suhaib Ahmed; and Dr. Jubie Selvaraj.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention provides a receptor-targeted dual-drug solid lipid nanoparticulate delivery system for the treatment of colorectal carcinoma. The system comprises irinotecan and da...